Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sex Hormones Influence HbA1c Levels in Non-Diabetic Population

By LabMedica International staff writers
Posted on 15 Apr 2022

Sex hormones, including estrogen, progesterone, and androgens, are synthesized by the human gonads and adrenal cortex. More...

Their main role is to promote development of the reproductive system and maintain secondary sexual characteristics.

Glycated hemoglobin (HbA1c) has long been regarded as the gold standard for evaluating long-term blood glucose control in patients living with diabetes in clinical routines. In recent years, standardized detection of HbA1c has been constantly improved, leading to sufficient sensitivity and specificity for HbA1c as an indicator of diabetes diagnosis.

Endocrinologists at the Shanghai Jiao Tong University (Shanghai, China) and their colleagues explore the extent of influence of sex hormones on HbA1c levels in non-diabetic population. A total of 1,409 non–diabetic subjects, including 601 men and 808 postmenopausal women were recruited from the local community. Venous blood samples were collected after a 10 hour overnight fast to detect fasting blood glucose (FPG), HbA1c, fasting insulin (FINS), blood lipids [total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein cholesterol (LDL-c)], and C-reactive protein (CRP). Additionally, all the non-diabetic subjects were tested for hemoglobin, and blood samples were collected after 75 g oral glucose tolerance test to determine the 2-h blood glucose (2hPG). All laboratory indicators were measured using the standard methods.

HbA1c level was measured by high performance liquid chromatography using the Variant II hemoglobin analyzer (Bio–Rad, Hercules, CA, USA), and hemoglobin level was measured by sodium lauryl sulfate colorimetry on the XE–2100 hematology analyzer, (Sysmex Corporation, Kobe, Japan). Serum insulin levels were measured with an electrochemiluminescence immunoassay on a Cobas e411 analyzer (Roche Diagnostics GmbH, Mannheim, Germany). Serum estradiol (E2), total testosterone (TT), and sex hormone binding globulin (SHBG) were detected on an Architect i2000SR analyzer by chemiluminescence microparticle immunoassay (Abbott GmbH & Co. KG, Wiesbaden, Germany).

The investigators reported that the level of HbA1c was 5.6 (5.4–5.9) % in all subjects, with 5.6 (5.4–5.8) % in men and 5.7 (5.5–5.9) % in postmenopausal women. Men had a median E2 level of 99.1 (84.4–121.1) pmol/L, median TT of 20.12 (15.5–24.9) nmol/L, median bioactive testosterone (BT) of 12.5 (10.0–15.9) nmol/L, and median SHBG of 40.7 (30.4–52.8) nmol/L. Postmenopausal women had a median E2 level of 36.7 (18.4–47.7) pmol/L, median TT of 0.9 (0.8–1.2) nmol/L, median BT of is 0.3 (0.2–0.3) nmol/L, and median SHBG of 53.7 (38.8–72.8) nmol/L After adjusting for age, body mass index (BMI), and hemoglobin, E2 was positively correlated with HbA1c in men and SHBG was inversely correlated with HbA1c in women. Other hormones were not correlated with HbA1c.

The authors concluded that sex hormones influence HbA1c levels in non-diabetic population. Moreover, levels of E2 were independently and positively correlated with HbA1c in men, and those of SHBG were independently and inversely correlated with HbA1c in postmenopausal women. The study was published on April 5, 2022 in the journal BMC Endocrine Disorders.

Related Links:
Shanghai Jiao Tong University 
Bio–Rad 
Sysmex Corporation 
Roche Diagnostics 
Abbott GmbH 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.